IRCT2017061734582N1已完成2 期
Evaluation the effect of adjuvant therapy with ciprofloxacin in non-surgical treatment of sever chronic periodontitis
zahdan university of medical siences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria :Age upper 18 years old? Presence of twenty teeth of least?Affection with spread mean to severe chronic periodontitisAt least (3-5 min clinical attachment loss in more thou 30 percent of the mouth areas .
- •Exclusion criteria: Lack of patient’s coloration? Antibiotic therapy doing the third past months?Allergy background for ciprofloxacin? Smoking people or addicted to tobacco? Affection with systemic diseases , which are effective on the periodontal conditions such as diabetes , blood disorders and immune system?
- •Pregnant women? Periodical Intervention Performance during the third past months?People who are under treatment with warfarin , antacid T and Cyclosporine.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the benefit of using hydroxychloroquine for uncomplicated term pregnancy in patients with primary obstetric antiphospholipid syndromePrimary obstetrical antiphospholipid syndromeMedDRA version: 20.0Level: PTClassification code 10002817Term: Antiphospholipid syndromeSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2017-004866-86-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)110
已完成
早期 1 期
The Effectiveness of the adjuvant treatment with a compound of sedge plant, saffron and honey to conventional treatment for improvement of cognitive performance of patients with dementiaIRCT2016101030255N1Vice Chancellor for research of Isfahan University of Medical Sciences60
进行中（未招募）
1 期
eo-adjuvant pembrolizumab in primary stage IV ovarian cancerEUCTR2016-004700-56-NLKI-AV30
已完成
不适用
Exploratory study of neo-adjuvant treatment with carboplatin, paclitaxel and pembrolizumab in primary stage IV serous ovarian cancerovarian cancerNL-OMON54749ederlands Kanker Instituut30
已完成
2 期
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II studyColon cancerJPRN-UMIN000006742Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group195